Vaccines
10 November 2014
Emergent BioSolutions Seeks Expanded BioThrax Label; Submits FDA Application for Post-Exposure Prophylaxis31 October 2014
Genexine’s HPV Therapeutic Vaccine Achieved High Efficacy in Phase I Cervical Dysplasia Trial28 October 2014
ImevaX secures EUR 7.5 million in Series A Financing to develop highly specific vaccine against Helicobacter pylori infections27 October 2014
Novavax Announces Ebola Vaccine Development Program at the 8th Vaccine and ISV Conference in Philadelphia27 October 2014
Novartis announces divestiture of influenza vaccines business to CSL for USD 275 million23 October 2014
NIH begins early human clinical trial of VSV Ebola vaccine23 October 2014
Vaxart Accelerates Development of Ebola Tablet Vaccin22 October 2014
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production21 October 2014
Immunovaccine Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine20 October 2014
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine17 October 2014
Updated Chordoma Data From Phase 1 Study of GI-6301 Presented at 2014 Connective Tissue Oncology Society (CTOS) Annual Meeting15 October 2014
Advaxis Provides Clinical Update for Phase 1/2 Trial of ADXS-HPV Immunotherapy Product Candidate in Anal CancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports